These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3138067)

  • 1. Canthaxanthine-induced retinal pigment epithelial changes in the cat.
    Scallon LJ; Burke JM; Mieler WF; Kies JC; Aaberg TM
    Curr Eye Res; 1988 Jul; 7(7):687-93. PubMed ID: 3138067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Canthaxanthin retinopathy and macular pucker].
    Bopp S; el-Hifnawi EL; Laqua H
    J Fr Ophtalmol; 1989; 12(12):891-6. PubMed ID: 2517961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Canthaxanthine retinopathy: 1. Clinical study in 51 consumers].
    Boudreault G; Cortin P; Corriveau LA; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1983 Dec; 18(7):325-8. PubMed ID: 6423246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Canthaxanthin retinopathy and macular pucker--clinical picture and ultrastructural findings of macular pucker].
    Bopp S; el-Hifnawi E; Laqua H
    Fortschr Ophthalmol; 1989; 86(5):456-60. PubMed ID: 2511128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold dust retinopathy after the ingestion of canthaxanthine to produce skin-bronzing.
    McGuinness R; Beaumont P
    Med J Aust; 1985 Dec 9-23; 143(12-13):622-3. PubMed ID: 3938522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after acute canthaxanthin application with small unilamellar phospholipid liposomes.
    Weber U; Michaelis L; Kern W; Goerz G
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(5):346-50. PubMed ID: 3117623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystalline retinopathy in patients taking an oral drug containing canthaxanthine.
    Ros AM; Leyon H; Wennersten G
    Photodermatol; 1985 Jun; 2(3):183-5. PubMed ID: 3927272
    [No Abstract]   [Full Text] [Related]  

  • 8. Canthaxanthin retinopathy. Anatomic and functional reversibility.
    Harnois C; Samson J; Malenfant M; Rousseau A
    Arch Ophthalmol; 1989 Apr; 107(4):538-40. PubMed ID: 2495787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrahigh-resolution optical coherence tomography of canthaxanthine retinal crystals.
    Chan A; Ko TH; Duker JS
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):138-9. PubMed ID: 16583635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application.
    Weber U; Kern W; Novotny GE; Goerz G; Hanappel S
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):198-205. PubMed ID: 3111945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carotinoid retinopathy. III. Reversibility].
    Weber U; Goerz G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):20-2. PubMed ID: 3959472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin.
    Goralczyk R; Buser S; Bausch J; Bee W; Zühlke U; Barker FM
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):741-52. PubMed ID: 9071228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Static perimetry in canthaxanthin maculopathy.
    Harnois C; Cortin P; Samson J; Boudreault G; Malenfant M; Rousseau A
    Arch Ophthalmol; 1988 Jan; 106(1):58-60. PubMed ID: 3122712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canthaxanthine retinopathy.
    Bloomenstein MR; Pinkert RB
    J Am Optom Assoc; 1996 Nov; 67(11):690-2. PubMed ID: 8979663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canthaxanthine (orobronze) retinopathy.
    McGuinness R; Beaumont P
    Aust N Z J Ophthalmol; 1986 Aug; 14(3):239-41. PubMed ID: 3094561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudoretinopathy caused by canthaxanthine].
    Maille M; Corbe C; Crepy P; Despreaux C; Montefiore G; Hamard H
    J Toxicol Clin Exp; 1988; 8(2):107-11. PubMed ID: 3137335
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructural alterations in rat and cat retina and pigment epithelium induced by chloroquine.
    Ivanina TA; Zueva MV; Lebedeva MN; Bogoslovsky AI; Bunin AJ
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(1):32-8. PubMed ID: 6832596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canthaxanthine retinopathy.
    Espaillat A; Aiello LP; Arrigg PG; Villalobos R; Silver PM; Cavicchi RW
    Arch Ophthalmol; 1999 Mar; 117(3):412-3. PubMed ID: 10088829
    [No Abstract]   [Full Text] [Related]  

  • 19. Canthaxanthine deposits in the eye.
    Rousseau A
    J Am Acad Dermatol; 1983 Jan; 8(1):123-4. PubMed ID: 6402526
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrosis and apoptosis in neuroretina and pigment epithelium after diffuse photodynamic action in rats: a light and electron microscopic study.
    Büchi ER; Szczesny PJ
    Jpn J Ophthalmol; 1996; 40(1):1-11. PubMed ID: 8739494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.